Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty
In acute myocardial infarction (AMI), timely reperfusion is a prerequisite to limit the extent of infarct size. Lee et al tested the hypothesis that abciximab, given at the time of primary angioplasty for AMI, may produce a greater degree of myocardial salvage.
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2002-12, Vol.90 (11), p.1243-1246 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1246 |
|---|---|
| container_issue | 11 |
| container_start_page | 1243 |
| container_title | The American journal of cardiology |
| container_volume | 90 |
| creator | Lee, Cheol Whan Moon, Dae-Hyuk Hong, Myeong-K.i Lee, Jae-Hwan Choi, S.i-Wan Yang, Hyun Suk Kim, Jae-Joong Park, Seong-Wook Park, Seung-Jung |
| description | In acute myocardial infarction (AMI), timely reperfusion is a prerequisite to limit the extent of infarct size. Lee et al tested the hypothesis that abciximab, given at the time of primary angioplasty for AMI, may produce a greater degree of myocardial salvage. |
| doi_str_mv | 10.1016/S0002-9149(02)02843-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72730027</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914902028436</els_id><sourcerecordid>72730027</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-9f835dce0725ea2586928d88e6f6cecfc3f8ffcb1b8329fe514d315a8b77e17c3</originalsourceid><addsrcrecordid>eNqFkU1rFTEUhoMo9lr9CUoQFF2M5mMySVZFSv2Aggt1HTKZk2vK3OSaZKr335v2DlbcuDoEnvfl5DwIPaXkDSV0ePuFEMI6TXv9irDXhKmed8M9tKFK6o5qyu-jzR_kBD0q5ao9KRXDQ3RCWS_IQOQGLRfeg6s4eWxHF36FnR1xinh3SM7mKdgZFztf2y3gEPHe1gCxFvwz1O_YuqXC32SI3mZXQ8svcYK8TSFu8T630nzANm5D2s-21MNj9MDbucCTdZ6ib-8vvp5_7C4_f_h0_u6ycz1VtdNecTE5IJIJsEyoQTM1KQWDHxw477hX3ruRjooz7UHQfuJUWDVKCVQ6fopeHnv3Of1YoFSzC8XBPNsIaSlGMsnbjWQDn_8DXqUlx7abYZxwSRTXDRJHyOVUSgZv1q8ZSsyNFHMrxdxc3LR5K8UMLfdsLV_GHUx3qdVCA16sgC3Ozj7b6EK543quhZB9486OHLSbXQfIprjmw8EUcpNophT-s8pvHlSq6g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230370839</pqid></control><display><type>article</type><title>Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lee, Cheol Whan ; Moon, Dae-Hyuk ; Hong, Myeong-K.i ; Lee, Jae-Hwan ; Choi, S.i-Wan ; Yang, Hyun Suk ; Kim, Jae-Joong ; Park, Seong-Wook ; Park, Seung-Jung</creator><creatorcontrib>Lee, Cheol Whan ; Moon, Dae-Hyuk ; Hong, Myeong-K.i ; Lee, Jae-Hwan ; Choi, S.i-Wan ; Yang, Hyun Suk ; Kim, Jae-Joong ; Park, Seong-Wook ; Park, Seung-Jung</creatorcontrib><description>In acute myocardial infarction (AMI), timely reperfusion is a prerequisite to limit the extent of infarct size. Lee et al tested the hypothesis that abciximab, given at the time of primary angioplasty for AMI, may produce a greater degree of myocardial salvage.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/S0002-9149(02)02843-6</identifier><identifier>PMID: 12450607</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Abciximab ; Aged ; Angioplasty ; Angioplasty, Balloon, Coronary ; Antibodies, Monoclonal - therapeutic use ; Biological and medical sciences ; Blood. Blood coagulation. Reticuloendothelial system ; Clinical outcomes ; Coronary Angiography ; Drug therapy ; Female ; Heart attacks ; Humans ; Immunoglobulin Fab Fragments - therapeutic use ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - therapy ; Myocardial Reperfusion Injury - prevention & control ; Pharmacology. Drug treatments ; Platelet Aggregation Inhibitors - therapeutic use ; Treatment Outcome</subject><ispartof>The American journal of cardiology, 2002-12, Vol.90 (11), p.1243-1246</ispartof><rights>2002 Excerpta Medica Inc.</rights><rights>2003 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Dec 1, 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-9f835dce0725ea2586928d88e6f6cecfc3f8ffcb1b8329fe514d315a8b77e17c3</citedby><cites>FETCH-LOGICAL-c418t-9f835dce0725ea2586928d88e6f6cecfc3f8ffcb1b8329fe514d315a8b77e17c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002914902028436$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14395574$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12450607$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Cheol Whan</creatorcontrib><creatorcontrib>Moon, Dae-Hyuk</creatorcontrib><creatorcontrib>Hong, Myeong-K.i</creatorcontrib><creatorcontrib>Lee, Jae-Hwan</creatorcontrib><creatorcontrib>Choi, S.i-Wan</creatorcontrib><creatorcontrib>Yang, Hyun Suk</creatorcontrib><creatorcontrib>Kim, Jae-Joong</creatorcontrib><creatorcontrib>Park, Seong-Wook</creatorcontrib><creatorcontrib>Park, Seung-Jung</creatorcontrib><title>Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>In acute myocardial infarction (AMI), timely reperfusion is a prerequisite to limit the extent of infarct size. Lee et al tested the hypothesis that abciximab, given at the time of primary angioplasty for AMI, may produce a greater degree of myocardial salvage.</description><subject>Abciximab</subject><subject>Aged</subject><subject>Angioplasty</subject><subject>Angioplasty, Balloon, Coronary</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Clinical outcomes</subject><subject>Coronary Angiography</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>Immunoglobulin Fab Fragments - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - therapy</subject><subject>Myocardial Reperfusion Injury - prevention & control</subject><subject>Pharmacology. Drug treatments</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1rFTEUhoMo9lr9CUoQFF2M5mMySVZFSv2Aggt1HTKZk2vK3OSaZKr335v2DlbcuDoEnvfl5DwIPaXkDSV0ePuFEMI6TXv9irDXhKmed8M9tKFK6o5qyu-jzR_kBD0q5ao9KRXDQ3RCWS_IQOQGLRfeg6s4eWxHF36FnR1xinh3SM7mKdgZFztf2y3gEPHe1gCxFvwz1O_YuqXC32SI3mZXQ8svcYK8TSFu8T630nzANm5D2s-21MNj9MDbucCTdZ6ib-8vvp5_7C4_f_h0_u6ycz1VtdNecTE5IJIJsEyoQTM1KQWDHxw477hX3ruRjooz7UHQfuJUWDVKCVQ6fopeHnv3Of1YoFSzC8XBPNsIaSlGMsnbjWQDn_8DXqUlx7abYZxwSRTXDRJHyOVUSgZv1q8ZSsyNFHMrxdxc3LR5K8UMLfdsLV_GHUx3qdVCA16sgC3Ozj7b6EK543quhZB9486OHLSbXQfIprjmw8EUcpNophT-s8pvHlSq6g</recordid><startdate>20021201</startdate><enddate>20021201</enddate><creator>Lee, Cheol Whan</creator><creator>Moon, Dae-Hyuk</creator><creator>Hong, Myeong-K.i</creator><creator>Lee, Jae-Hwan</creator><creator>Choi, S.i-Wan</creator><creator>Yang, Hyun Suk</creator><creator>Kim, Jae-Joong</creator><creator>Park, Seong-Wook</creator><creator>Park, Seung-Jung</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20021201</creationdate><title>Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty</title><author>Lee, Cheol Whan ; Moon, Dae-Hyuk ; Hong, Myeong-K.i ; Lee, Jae-Hwan ; Choi, S.i-Wan ; Yang, Hyun Suk ; Kim, Jae-Joong ; Park, Seong-Wook ; Park, Seung-Jung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-9f835dce0725ea2586928d88e6f6cecfc3f8ffcb1b8329fe514d315a8b77e17c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Abciximab</topic><topic>Aged</topic><topic>Angioplasty</topic><topic>Angioplasty, Balloon, Coronary</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Clinical outcomes</topic><topic>Coronary Angiography</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>Immunoglobulin Fab Fragments - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - therapy</topic><topic>Myocardial Reperfusion Injury - prevention & control</topic><topic>Pharmacology. Drug treatments</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Cheol Whan</creatorcontrib><creatorcontrib>Moon, Dae-Hyuk</creatorcontrib><creatorcontrib>Hong, Myeong-K.i</creatorcontrib><creatorcontrib>Lee, Jae-Hwan</creatorcontrib><creatorcontrib>Choi, S.i-Wan</creatorcontrib><creatorcontrib>Yang, Hyun Suk</creatorcontrib><creatorcontrib>Kim, Jae-Joong</creatorcontrib><creatorcontrib>Park, Seong-Wook</creatorcontrib><creatorcontrib>Park, Seung-Jung</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Cheol Whan</au><au>Moon, Dae-Hyuk</au><au>Hong, Myeong-K.i</au><au>Lee, Jae-Hwan</au><au>Choi, S.i-Wan</au><au>Yang, Hyun Suk</au><au>Kim, Jae-Joong</au><au>Park, Seong-Wook</au><au>Park, Seung-Jung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2002-12-01</date><risdate>2002</risdate><volume>90</volume><issue>11</issue><spage>1243</spage><epage>1246</epage><pages>1243-1246</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>In acute myocardial infarction (AMI), timely reperfusion is a prerequisite to limit the extent of infarct size. Lee et al tested the hypothesis that abciximab, given at the time of primary angioplasty for AMI, may produce a greater degree of myocardial salvage.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>12450607</pmid><doi>10.1016/S0002-9149(02)02843-6</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2002-12, Vol.90 (11), p.1243-1246 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72730027 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Abciximab Aged Angioplasty Angioplasty, Balloon, Coronary Antibodies, Monoclonal - therapeutic use Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Clinical outcomes Coronary Angiography Drug therapy Female Heart attacks Humans Immunoglobulin Fab Fragments - therapeutic use Male Medical sciences Middle Aged Myocardial Infarction - therapy Myocardial Reperfusion Injury - prevention & control Pharmacology. Drug treatments Platelet Aggregation Inhibitors - therapeutic use Treatment Outcome |
| title | Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T03%3A32%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20abciximab%20on%20myocardial%20salvage%20in%20patients%20with%20acute%20myocardial%20infarction%20undergoing%20primary%20angioplasty&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Lee,%20Cheol%20Whan&rft.date=2002-12-01&rft.volume=90&rft.issue=11&rft.spage=1243&rft.epage=1246&rft.pages=1243-1246&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/S0002-9149(02)02843-6&rft_dat=%3Cproquest_cross%3E72730027%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230370839&rft_id=info:pmid/12450607&rft_els_id=S0002914902028436&rfr_iscdi=true |